NEW YORK, June 2, 2023 /PRNewswire/ — Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, announces preliminary data from a...
The company will also present an update on its corporate and clinical progress at the event NEW YORK, May 31, 2023 /PRNewswire/ — Promontory Therapeutics Inc.,...
